Literature DB >> 22391350

Isolated metastatic primary peritoneal carcinoma to the breast: a rare site of disease recurrence.

P E Coyne1, L Kenny, E Barnes, R Westley, E Ward, M Jain, O Iwuchukwu.   

Abstract

Primary breast carcinoma is a common pathology in the UK. It can present with metastatic deposits but it is rare that lesions in the breast are the sole primary or secondary presentation for metastatic cancer from other sources. We present a case of a primary peritoneal cancer recurring after optimal treatment with a new breast lesion and the diagnostic difficulties that this can cause.

Entities:  

Mesh:

Year:  2012        PMID: 22391350      PMCID: PMC5827243          DOI: 10.1308/003588412X13171221502068

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


  4 in total

1.  Secondary breast cancer: a 5-year population-based study with review of the literature.

Authors:  Tor Audun Klingen; Herman Klaasen; Hans Aas; Ying Chen; Lars A Akslen
Journal:  APMIS       Date:  2009-10       Impact factor: 3.205

2.  Characteristics of metastasis in the breast from extramammary malignancies.

Authors:  Se Kyung Lee; Wan Wook Kim; Sung Hoon Kim; Sung Mo Hur; Sangmin Kim; Jae Hyuck Choi; Eun Yoon Cho; Soo Yeon Han; Boo-Kyung Hahn; Jun-Ho Choe; Jung-Han Kim; Jee Soo Kim; Jeong Eon Lee; Seok Jin Nam; Jung-Hyun Yang
Journal:  J Surg Oncol       Date:  2010-02-01       Impact factor: 3.454

3.  Breast metastasis 56 months before the diagnosis of primary ovarian cancer: a case study.

Authors:  Susanne E Schneuber; Heinz S Scholz; Peter Regitnig; Edgar Petru; Raimund Winter
Journal:  Anticancer Res       Date:  2008 Sep-Oct       Impact factor: 2.480

4.  Ovarian cancer metastatic to the breast presenting as inflammatory breast cancer: a case report and literature review.

Authors:  Rebecca L Klein; Amanda R Brown; Christian M Gomez-Castro; Setsuko K Chambers; Janiel M Cragun; Lauren Grasso-Lebeau; Julie E Lang
Journal:  J Cancer       Date:  2010-06-02       Impact factor: 4.207

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.